WeVote
Log In

Bill

Bill

HB 917

Compounding pharmacies; use of bulk drug substances, recordkeeping.

2026 Regular Session Introduced by Liz Guzmán and 1 co-sponsor

Virginia bill establishes recordkeeping requirements and bulk substance-use regulations for compounding pharmacies to enhance safety oversight and accountability.

Continued to next session in Health and Human Services (Voice Vote)
0
WeVote Research Nonpartisan
Bill Summary · HB 917

Legislative bill overview

HB 917 regulates how compounding pharmacies in Virginia can use bulk drug substances and establishes recordkeeping requirements for these operations. The bill appears designed to create oversight mechanisms for pharmacies that create customized medications by combining individual ingredients rather than dispensing pre-manufactured drugs.

Why is this important

Compounding pharmacies serve patients with specific medical needs—such as those requiring custom dosages or ingredient modifications—but have faced scrutiny following contamination incidents that harmed patients nationally. Clear recordkeeping and substance-use standards help protect public health by enabling regulatory tracking and accountability while maintaining access to these specialized services.

Potential points of contention

  • Regulatory burden vs. access: Stricter recordkeeping requirements could increase operational costs for small compounding pharmacies, potentially reducing availability of customized medications in rural areas or for niche medical needs
  • Scope of "bulk drug substances": Disagreement likely exists over which substances should be regulated and how restrictively, balancing safety against pharmacy flexibility to serve patients with uncommon requirements
  • Enforcement and inspection resources: The bill may require additional state funding for the Board of Pharmacy to conduct inspections and monitor compliance, raising questions about fiscal feasibility and implementation timelines

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.